BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5477308)

  • 1. Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain.
    Persson T; Waldeck B
    Eur J Pharmacol; 1970; 11(3):315-20. PubMed ID: 5477308
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
    Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
    [No Abstract]   [Full Text] [Related]  

  • 3. On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.
    Svensson TH; Waldeck B
    Eur J Pharmacol; 1969 Sep; 7(3):278-82. PubMed ID: 5351985
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of some psychoactive drugs on central monoamine neurons.
    Corrodi H; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Sep; 1(5):363-8. PubMed ID: 5587552
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of apomorphine and amphetamine on schedule-controlled behavior: reversal of tetrabenazine suppression and dopaminergic correlates.
    Butcher LL; Andén NE
    Eur J Pharmacol; 1969; 6(3):255-64. PubMed ID: 5799188
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons.
    Thierry AM; Blanc G; Glowinski J
    Eur J Pharmacol; 1971 May; 14(3):303-7. PubMed ID: 4405541
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of lithium on cerebral monoamine neurons.
    Corrodi H; Fuxe K; Hökfelt T; Schou M
    Psychopharmacologia; 1967; 11(4):345-53. PubMed ID: 5590421
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 12. Some problems encountered in attempting to estimate catecholamine turnover using lbbelled tyrosine.
    Persson T; Waldeck B
    J Pharm Pharmacol; 1970 Jul; 22(7):473-8. PubMed ID: 4395050
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical mechanism of toxicity of fungicides of the dithiocarbamate series: inhibitory action on dopamine -hydroxylase activity].
    Truhaut R; Guérinot F; Bohuon C
    Ann Pharm Fr; 1971 Feb; 29(2):117-23. PubMed ID: 5559013
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral and catecholamine depleting effects of alpha-methyl-5-hydroxytryptophan.
    Dominic JA; Moore KE
    Eur J Pharmacol; 1969 Dec; 8(3):292-5. PubMed ID: 5308817
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of rat brain tryptophan hydroxylase by 6-halotryptophans.
    McGeer EG; Peters DA; McGeer PL
    Life Sci; 1968 Jun; 7(12):605-15. PubMed ID: 5672661
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 18. A reduced rate of turnover of brain noradrenaline during pentobarbitone anaesthesia.
    Persson T; Waldeck B
    J Pharm Pharmacol; 1971 May; 23(5):377-8. PubMed ID: 4396984
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of norepinephrine contents in neuronal cell bodies and terminals during and after cessation of preganglionic stimulation.
    Bhatnagar RK; Moore KE
    J Pharmacol Exp Ther; 1972 Feb; 180(2):265-76. PubMed ID: 5062299
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
    Carlsson A; Engel J; Strömbom U; Svensson TH; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):117-28. PubMed ID: 4278296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.